Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Next Science Ltd (AU:NXS)
:NXS
Holding AU:NXS?
Track your performance easily
Earnings Data
Report Date
Feb 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.03Last Year’s EPS
-0.03Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 15, 2019
|% Change Since: -30.00%
|Next Earnings Date:Mar 29, 2019
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant growth in the Surgical business and improved gross margins, but these were offset by declines in DME and BLASTX sales due to sales force restructuring. The company remains optimistic by reaffirming revenue guidance and implementing strategic changes. However, the establishment of a loan facility indicates caution. Overall, the sentiment leans towards optimism but with notable areas of concern.Company Guidance
During the Q2 2024 earnings call for Next Science, the management team provided guidance, projecting FY '24 revenue between USD 36 million to USD 40 million, and reaffirmed expectations to achieve EBITDA and cash flow positivity in the second half of the fiscal year. The company reported Q2 product sales of USD 5.8 million, marking a 5% increase over the prior period, with direct channel product sales contributing USD 4.4 million, accounting for 76% of the total. Despite a 22% decline in DME sales and a 6% drop in BLASTX direct sales due to a sales force restructuring, the Surgical business saw a 72% increase in direct sales of XPERIENCE. The quarter ended with a gross margin of 80%, surpassing the previous year's 69%, supported by an increase in payers to over 120. Cash receipts rose by 11% from Q1 to USD 6 million, with net operating cash outflows reduced to USD 1.3 million. The company aims to leverage the growing body of clinical evidence and broader healthcare site access to drive future growth.Surgical Business Growth
Direct sales of XPERIENCE increased by 72% over the prior period and 25% over the first quarter of 2024.
Improved Gross Margin
The company's gross margin increased to 80% in Q2, up from 69% in the second quarter of 2023, reflecting a continued focus on revenue quality.
Cash Position and Cost Management
Cash receipts for the quarter were USD 6 million, up 11% compared to Q1 2024. Net operating cash outflows decreased to USD 1.3 million from USD 3.7 million in the previous quarter.
Expansion of Payers
Next Science onboarded over 120 payers for the DME business, including private and government payers such as Medicare and Medicaid.
FY '24 Revenue Guidance Reaffirmed
The company reaffirmed its FY '24 revenue guidance of USD 36 million to USD 40 million and expects to be EBITDA and cash flow positive in the second half of FY '24.
---
AU:NXS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AU:NXS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 29, 2024 | AU$0.20 | AU$0.21 | +5.00% |
| Apr 24, 2024 | AU$0.42 | AU$0.32 | -25.00% |
| Feb 27, 2024 | AU$0.34 | AU$0.32 | -7.25% |
| Aug 30, 2023 | AU$0.65 | AU$0.52 | -20.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Next Science Ltd (AU:NXS) report earnings?
Next Science Ltd (AU:NXS) is schdueled to report earning on Feb 26, 2025, TBA Not Confirmed.
What is Next Science Ltd (AU:NXS) earnings time?
Next Science Ltd (AU:NXS) earnings time is at Feb 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Next Science Ltd stock?
The P/E ratio of Next Science Ltd is N/A.
What is AU:NXS EPS forecast?
AU:NXS EPS forecast for the fiscal quarter 2024 (Q4) is -0.03.
---